Genelux (GNLX) EPS (Weighted Average and Diluted) (2022 - 2025)
Genelux (GNLX) has 3 years of EPS (Weighted Average and Diluted) data on record, last reported at -$0.19 in Q3 2024.
- For Q3 2024, EPS (Weighted Average and Diluted) rose 5.0% year-over-year to -$0.19; the TTM value through Sep 2024 reached -$0.95, up 26.92%, while the annual FY2023 figure was -$1.16, 103.51% down from the prior year.
- EPS (Weighted Average and Diluted) reached -$0.19 in Q3 2024 per GNLX's latest filing, up from -$0.22 in the prior quarter.
- Across five years, EPS (Weighted Average and Diluted) topped out at -$0.19 in Q2 2023 and bottomed at -$0.53 in Q1 2023.
- Average EPS (Weighted Average and Diluted) over 3 years is -$0.28, with a median of -$0.23 recorded in 2023.
- The widest YoY moves for EPS (Weighted Average and Diluted): up 45.28% in 2024, down 15.79% in 2024.
- A 3-year view of EPS (Weighted Average and Diluted) shows it stood at -$0.38 in 2022, then surged by 34.21% to -$0.25 in 2023, then rose by 24.0% to -$0.19 in 2024.
- Per Business Quant database, its latest 3 readings for EPS (Weighted Average and Diluted) were -$0.19 in Q3 2024, -$0.22 in Q2 2024, and -$0.29 in Q1 2024.